Navigation Links
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
Date:12/8/2008

n levels increased from a median of 7.6 g/dL (7.9 +/- 0.3) at baseline to a median of 9.0 g/dL (8.9 +/- 0.4) following 12 weeks of Soliris treatment (P<0.001). -- Patient fatigue levels, as measured by the FACIT-Fatigue instrument, significantly improved within one week of Soliris treatment, with a median increase of 5.0 points at 12 weeks (P<0.001). A change of three or more points is considered clinically meaningful. -- An exploratory analysis was also performed to evaluate the effect of Soliris on Chronic Kidney Disease (CKD), measured as an improvement or worsening in CKD stage during treatment according to the KDOQI CKD published guidelines. (3) Chronic eculizumab treatment was associated with a 12-fold likelihood of an improvement in CKD level (P<0.001;CKD improved in 41 percent (12/29) of patients, CKD was unchanged in 55 percent (16/29), CKD worsened in 3.4 percent (1/29)).

The drug appeared to be safe and well tolerated in study patients. The most frequent adverse events (AEs) were headache (52 percent), nasopharyngitis (41 percent), and nausea (21 percent). Most AEs were mild to moderate in severity. No serious AEs related to study drug were reported following treatment with Soliris.

"The AEGIS results show that Soliris treats the hallmarks of PNH in Japanese patients with levels of safety and efficacy consistent with those demonstrated in U.S. and European study populations," said Leonard Bell, M.D., Chief Executive Officer of Alexion. "This is an important step in the process of bringing Soliris to the substantial numbers of patients with PNH in Japan, which is tied to our objective that every patient who can benefit from Soliris will have access to Soliris."

The AEGIS study was authorized by Japan's Pharmaceutical and Medical Device Administration (PMDA). Alexion expects to include data
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
2. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
4. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
5. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
6. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
7. GEN Reports on the Trend Toward Predictive Toxicogenomics
8. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
9. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
10. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
11. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Kan. , Dec. 18, 2014   ... ), a biopharmaceutical company focused on the licensing, ... animals, today announced positive results from its pivotal ... drug for treating pain in dogs with osteoarthritis. ... in pain assessment scores that were statistically significant ...
(Date:12/19/2014)... separating membrane market has witnessed robust development with the growth ... a later starter. In 2012, the size of ... with the proportion worldwide soaring to 16.3%. It is projected ... continue its growth rate by around 20% in the upcoming ... roughly RMB25 billion. An integrated membrane industrial system ...
(Date:12/17/2014)... STUTTGART , Alemania, December 17, 2014 ... del año anterior, con un alto nivel de gasto ... pasado año fiscal 2013/14 (finalizado el 30 de septiembre ... por ciento a 4.287 millones de euros (año anterior: ... de la moneda desfavorables. Las ganancias (EBIT) crecieron un ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS confirma su posición en un entorno difícil 2
... , Jan. 17 In the last decade, ... with a staggering 4000% increase in the diagnosis of bipolar ... prescriptions for antidepressants in 2008. Pharmaceutical companies spend billions of ... there a connection? And when a patient experiences harm from ...
... , LOS ANGELES , Jan. 16 ... Tuesday, 4 Survival To Go , an emergency preparedness company based in ... Mourning to help provide aid to the impoverished nation via the newly ... of February, 4 Survival To Go will donate 20% of online ...
Cached Medicine Technology:Pharmaceutical Direct to Consumer Advertising on The American Law Journal 2Pharmaceutical Direct to Consumer Advertising on The American Law Journal 3Help the Haitian Community and Prepare for an Unexpected Disaster 2Help the Haitian Community and Prepare for an Unexpected Disaster 3Help the Haitian Community and Prepare for an Unexpected Disaster 4
(Date:12/21/2014)... 2014 Over the past 39 years, ... hundreds of emergency departments across the nation, from quality ... been translated into an innovative suite of tools, systems, ... and enhance the patient experience. , NES Health, ... and management services for hospitals, announced the development and ...
(Date:12/21/2014)... The Oncology Institute of Hope and Innovation ... and Whittier offices. The Hope for the Holidays Toy Drive ... and their families during the holiday season. This year, the ... children between both offices. This event continues to be successful ... service team, store managers and assistant managers came out and ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 Weddingshe.com has ... and launched a site-wide promotion of special occasion dresses ... a popular supplier of special occasion dresses for global ... offered with big discounts, up to 80% off. Among ... Sweetheart Sequins Short Sweet 16 Dress) is very popular. ...
(Date:12/20/2014)... News) -- The holidays can be anything but joyous ... trees, scented candles and other allergy triggers. "The ... have been packed away in dank basements or dusty ... patients," Dr. Rachna Shah, an affiliate faculty member at ... Loyola news release. Shah, who is also an ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 Atore, Inc, ... company just launched first birthday focused portal on December ... BIRTHDAY MESSAGE” launched in both US and Japan. , ... MESSAGE : http://merrybirthday.net/message/ , MERRY BIRTHDAY MESSAGE ... birthday around the world. , Features, Choose from thousands ...
Breaking Medicine News(10 mins):Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:Holiday Trimmings Can Trigger Allergies 2Health News:Atore, Inc. Releasing the First Birthday Portal 2
... shows promise for reducing bacterial growth , , FRIDAY, ... may help fight strep infections have been identified ... more common among infection-causing bacteria, researchers have warned. ... involves new antimicrobial agents that suppress bacteria virulence ...
... twins, Tracy and Lanny Barnes are ranked among the top competitors in ... the gold at the 2010 Winter Games to be held in Vancouver, ... made with hot pepper extract for helping them get the most out ... ...
... Lombardi Comprehensive Cancer Center and Capital Breast Care Center ... breast cancer screening to underserved women at the annual ... is the second year the AVON Foundation has recognized ... Care Center to their dedication to breast cancer prevention ...
... Bush Administration Proposal at Odds With Intent of Economic Stimulus, ... 1 Reaching back in time to propose implementing a ... seniors, Medicare funding by $1.05 billion in FY 2010 (estimated ... odds with the intent of the American Recovery and ...
... with cancer that is resistant to standard therapy is the ... obtained in some settings, in many cases the therapies have ... has now been uncovered by a team of researchers, led ... London School of Medicine and Dentistry, London. , In the ...
... Horizons Family Solutions LLC , the world,s leading provider ... and work/life solutions, today announced a new emergency or ... families manage during times of public health emergencies, like ... schools are closed and regular child care is not ...
Cached Medicine News:Health News:Twin Sisters Set Their Sights On Biathlon Gold At The 2010 Winter Games 2Health News:Lombardi Cancer Center and the Capital Breast Care Center awarded $750,000 from the AVON Foundation 2Health News:AHCA/Alliance: New Medicare Regulation Will Hurt Seniors, Cost Jobs, Perpetuate Inefficiency 2Health News:AHCA/Alliance: New Medicare Regulation Will Hurt Seniors, Cost Jobs, Perpetuate Inefficiency 3Health News:Bright Horizons Responds to National Health Emergency With Pandemic Alert Back-Up Child Care Solutions 2Health News:Bright Horizons Responds to National Health Emergency With Pandemic Alert Back-Up Child Care Solutions 3
...
...
...
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Shaft angled 45 degrees. Manufactured in titanium....
Medicine Products: